Related Experiment Video
Updated: Feb 15, 2026

Author Spotlight: Enhancing Vascular Function and Physical Capacity in Cardiovascular Disease Through Novel Interventions and NIRS Technology
Published on: March 22, 2024
Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable
Valérie Devauchelle-Pensec1,2, Lea Saraux1,3, Jean Marie Berthelot4
1Rheumatology Department, CHU Brest,, Brest, France.
Objective:
The PMR activity score (PMR-AS) includes the CRP value, which may be lacking or invalid owing to anti-IL-6 therapy. Our objective was to develop alternatives to PMR-AS that do not require CRP.
Methods:
We used the Club Rhumatisme et Inflammation (CRI; 89 patients with PMR) and the Tolerance and Efficacy of tocilizumab iN pOlymyalgia Rheumatica (TENOR; 20 patients with recent-onset PMR naive to glucocorticoid who received three tocilizumab infusions, at weeks 0, 4 and 8, followed by prednisone from weeks 12 to 24) cohorts. In the CRI cohort, we evaluated correlations between PMR-AS items to select the best item for imputing CRP. Then we calculated the PMR-AS with (PMR-AS) and without (clin-PMR-AS) CRP and we used the linear regression between PMR-AS and clin-PMR-AS to obtain CRP-imputed (CRP-imp) PMR-AS. Finally, we evaluated agreement between clin-PMR-AS, CRP-imp PMR-AS, PMR-AS and ESR-PMR-AS in the TENOR cohort during tocilizumab therapy.
Results:
In the CRI cohort, agreement between PMR-AS and clin-PMR-AS was excellent (κ = 0.90). Linear regression between PMR-AS and clin-PMR-AS [CRP-imp PMR-AS = 1.12(clin-PMR-AS)+0.26] allowed us to build the CRP-imp PMR-AS. Mean (s.d.) values were as follows: 8.40 (9.76) for PMR-AS, 7.24 (8.58) for clin-PMR-AS and 7.84 (9.61) for CRP-imp PMR-AS. CRP-imp PMR-AS agreed more closely with PMR-AS than did clin-PMR-AS. The results in the TENOR cohort confirmed that CRP-imp PMR-AS or ESR-PMR-AS could be used.
Conclusion:
Alternatives to the PMR-AS obtained without CRP can be used to monitor PMR activity in everyday practice in patients without available CRP values and in those receiving IL-6 antagonist therapy.
Insights
New polymyalgia rheumatica activity scores (PMR-AS) were developed without C-reactive protein (CRP) for patients on anti-IL-6 therapy. These CRP-independent scores accurately monitor PMR disease activity in clinical practice.
Area of Science:
- Rheumatology
- Clinical Trial Methodology
- Biomarker Validation
Background:
- The Polymyalgia Rheumatica Activity Score (PMR-AS) relies on C-reactive protein (CRP), which is often unavailable or invalid during anti-interleukin-6 (IL-6) therapy.
- This limitation hinders accurate monitoring of polymyalgia rheumatica (PMR) disease activity in patients receiving specific treatments.
Purpose of the Study:
- To develop and validate alternative PMR activity scores that do not require CRP measurements.
- To enable reliable assessment of PMR activity in patients undergoing anti-IL-6 therapy or with missing CRP data.
Main Methods:
- Utilized two patient cohorts (CRI and TENOR) with PMR.
- Correlated PMR-AS components to impute CRP values, creating a CRP-imputed PMR-AS (CRP-imp PMR-AS).
- Evaluated the agreement between the original PMR-AS, a CRP-independent clinical PMR-AS (clin-PMR-AS), and the CRP-imp PMR-AS in both cohorts.
Main Results:
- Excellent agreement (κ = 0.90) was observed between PMR-AS and clin-PMR-AS in the CRI cohort.
- The developed CRP-imp PMR-AS showed closer agreement with the original PMR-AS compared to clin-PMR-AS.
- Validation in the TENOR cohort confirmed the utility of CRP-imp PMR-AS and ESR-PMR-AS during tocilizumab treatment.
Conclusions:
- Alternative PMR activity scores that exclude CRP are feasible and reliable.
- These CRP-independent scores can be effectively used in routine clinical practice for monitoring PMR activity.
- The findings support the use of these modified scores for patients with unavailable CRP values or on IL-6 antagonist therapy.
Related Concept Videos
Activation and Inactivation of G Proteins
Cross-reactivity
Reactivity of Enols
Reactivity of Enolate Ions
Radical Reactivity: Overview
Radical Reactivity: Nucleophilic Radicals

